Convalescents with ongoing long-term symptoms displayed a tendency towards increased anti-nucleocapsid and anti-spike IgG antibody levels five to six weeks after the first infection, whereas for anti-spike IgA, no trend was observed (Figure 1). Here, CD79A is linked to infection.